BIRC3 is a novel driver of therapeutic resistance in Glioblastoma.
about
Genome-wide RNA-Sequencing analysis identifies a distinct fibrosis gene signature in the conjunctiva after glaucoma surgeryHistologically defined intratumoral sequencing uncovers evolutionary cues into conserved molecular events driving gliomagenesis.Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma.Impact of inhibitor of apoptosis proteins on immune modulation and inflammation.BIRC3 is a biomarker of mesenchymal habitat of glioblastoma, and a mediator of survival adaptation in hypoxia-driven glioblastoma habitats.Recurring Amplification at 11q22.1-q22.2 Locus Plays an Important Role in Lymph Node Metastasis and Radioresistance in OSCC.Magnetic hyperthermia therapy for the treatment of glioblastoma: a review of the therapy's history, efficacy, and application in humans.Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide.Bioinformatic analysis of gene expression and methylation regulation in glioblastoma.CircDOCK1 suppresses cell apoptosis via inhibition of miR‑196a‑5p by targeting BIRC3 in OSCC.Baculoviral IAP Repeat Containing 6 (BIRC6) Is a Predictor of Prognosis in Prostate Cancer.A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells.Drug Repositioning in Glioblastoma: A Pathway Perspective.Minority stress and leukocyte gene expression in sexual minority men living with treated HIV infection.Integrated analyses of multi-omics reveal global patterns of methylation and hydroxymethylation and screen the tumor suppressive roles of HADHB in colorectal cancer.
P2860
Q33912109-FF6771DC-C90F-4310-A96F-9CE455F601B0Q36379857-4D8436B9-E12B-418B-9890-8340FD0D5029Q37672257-ECF8CA60-36C5-4763-8BC9-D9D813F1D549Q38974466-FE1EB162-F0DA-4CE0-8636-406AEE56122BQ41516352-15DEDEE3-8E91-43D9-ADEB-255310500391Q47134212-2AA789C7-20C7-4305-9FF4-0F7C73CA777AQ47721799-4F303ACA-8385-446B-B37B-BB9BC1D25ADEQ47935571-C9F98095-9C9C-42FA-8128-A36246640CCCQ48249383-87FE8467-9019-4A1C-9E1A-FD85CE90B83EQ49500417-A6E4510C-9BF1-412C-AACA-D87997146CFFQ50074531-323A2AF2-DBC8-47DC-A73C-CC22FEC804BEQ51746123-4C498A07-D6A3-4FD7-8783-7E3289AD2474Q52608766-1B35CF77-44CA-44C0-B314-5D987C6F76A3Q54254509-67A906B4-ABB9-46E5-A153-E51B629648E1Q55260344-D5E2EA9C-62B1-414B-981B-BFDF5E0E8888
P2860
BIRC3 is a novel driver of therapeutic resistance in Glioblastoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
BIRC3 is a novel driver of therapeutic resistance in Glioblastoma.
@ast
BIRC3 is a novel driver of therapeutic resistance in Glioblastoma.
@en
type
label
BIRC3 is a novel driver of therapeutic resistance in Glioblastoma.
@ast
BIRC3 is a novel driver of therapeutic resistance in Glioblastoma.
@en
prefLabel
BIRC3 is a novel driver of therapeutic resistance in Glioblastoma.
@ast
BIRC3 is a novel driver of therapeutic resistance in Glioblastoma.
@en
P2093
P2860
P356
P1433
P1476
BIRC3 is a novel driver of therapeutic resistance in Glioblastoma.
@en
P2093
Anders Berglund
Arnold B Etame
Dapeng Wang
James J Mulé
Peter A Forsyth
Rajappa S Kenchappa
P2860
P2888
P356
10.1038/SREP21710
P407
P577
2016-02-18T00:00:00Z
P5875
P6179
1049153239